Related Experiment Videos
New cytogenetic subtype of renal tumors
Cancer Genetics and Cytogenetics
|June 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cytogenetic and fluorescence in situ hybridization analysis of breast fibroadenomas.
Cancer genetics and cytogenetics·1992
Application of fluorescence in situ hybridization in hematological disorders.
Cancer genetics and cytogenetics·1992
Cytogenetic and molecular studies of a familial renal cell carcinoma.
Cancer genetics and cytogenetics·1992
Isolation of a yeast artificial chromosome clone that spans the (12;16) translocation breakpoint characteristic of myxoid liposarcoma.
Cancer genetics and cytogenetics·1992
Cytogenetic and FISH studies of abnormal X chromosomes in a patient with ANLL.
Cancer genetics and cytogenetics·1992
A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.
Cancer genetics and cytogenetics·2010
Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma.
Cancer genetics and cytogenetics·2010
Screening for DNA copy number aberrations in mucinous adenocarcinoma arising from the minor salivary gland: two case reports.
Cancer genetics and cytogenetics·2010
Screening for common copy-number variants in cancer genes.
Cancer genetics and cytogenetics·2010
Trisomy 17 in congenital plexiform (multinodular) cellular schwannoma.
Cancer genetics and cytogenetics·2010
Chromosomal alterations in Malaysian patients with nasopharyngeal carcinoma analyzed by comparative genomic hybridization.
Cancer genetics and cytogenetics·2010
TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.
The Journal of experimental medicine·2026
Activation of PP2A-B56a leads to aberrant EGFR signaling and proliferative phenotypes in PDAC.
Molecular cancer therapeutics·2026
Toward Fit-for-Purpose Data for Drug Assessment in Non-small Cell Lung Cancer: A Core Dataset.
Clinical pharmacology and therapeutics·2026
Payload-Free [89Zr]Zr-DFO*-sq-Enfortumab ImmunoPET for Imaging Nectin-4 Expression in Bladder Cancer.
Molecular pharmaceutics·2026